SCHEMBL4891786

SCHEMBL4891786

COc1nc(NC(=O)c2cnn(-c3ccc(Cl)cc3)c2C(F)(F)F)c(C(=O)O)n1-c1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 3/20 0.42
MAPT P10636 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MALT1 Q9UDY8 4/20 0.41
MET P08581 2/20 0.40
MST1R Q04912 1/20 0.40
HSD11B1 P28845 1/20 0.40
HPGD P15428 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TRPC3 Q13507 2/20 0.40
PTPN1 P18031 1/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4897158 0.91 MAPT (0.41) ALDH1A1KDM4EMAPTLMNAHTT
SCHEMBL4789019 0.81 SMN1; SMN2 (0.41) ALDH1A1KDM4EMAPTSMN1; SMN2MEN1
SCHEMBL4788948 0.80 KMT2A (0.43) ALDH1A1MAPTSMN1; SMN2LMNAMEN1
SCHEMBL2856449 0.75 MAPT (0.50) ALDH1A1KDM4EMAPTSMN1; SMN2POLB
SCHEMBL3441956 0.74 ALDH1A1 (0.45) ALDH1A1KDM4EMAPTSMN1; SMN2POLB
SCHEMBL2857034 0.73 KDM4E (0.62) ALDH1A1KDM4EMAPTSMN1; SMN2POLB
SCHEMBL4885880 0.73 CNR1 (0.39) ALDH1A1KDM4EMAPTSMN1; SMN2HPGD
SCHEMBL13513716 0.73 POLB (0.59) ALDH1A1KDM4EMAPTPOLBLMNA
SCHEMBL2852931 0.72 KDM4E (0.57) ALDH1A1KDM4EMAPTSMN1; SMN2POLB
SCHEMBL2064195 0.72 MAPT (0.76) ALDH1A1KDM4EMAPTSMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008130313-A1 IMIDAZOLE DERIVATIVES AS MODULATORS OF THE GABA RECEPTOR FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS ASTRAZENECA AB (SE) 2008-10-30 WO disclosed